Obermatt

Sigma Healthcare

ASX:SIG · AU000000SIG5
Health Care Providers & ServicesLarge

360

60
EV / EBIT25
Price / Owner Earnings25
Owner Earnings Yield39
Dividend Yield71
Price/Sales32
EV / Gross Profit8
Price/Book13
Returns on capital68
EBIT Margin51
Gross Profitability39
Cash Conversion4
Accruals69
Owner Earnings Margin72
Sales growth100
Profit Growth78
Long-Term EPS Growth82
Owner Earnings Growth67
Reinvestment43
Price momentum50
Debt load40
Refinancing26
Debt Payback70
Liquidity55
Analyst ratings45
Opinion Changes78
Price Target Upside72
Market mood100
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sigma Healthcare generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryAustralia
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeASX
Founded1999
ISINAU000000SIG5
Last UpdateApr 2, 2026

Description

Analysis

Hope premium

Sigma Healthcare Limited is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium.

On valuation, the picture is expensive. The owner-earnings multiple stands at 53.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 19% a year, against analyst forecasts of 22%. The price, in other words, assumes less than the experts do.

Growth is solid; the safety picture is sturdy. The company scores 16/20 on our value-creation score: strong value creator.

Flags to be aware of: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
49
2023202420252026

All-time high

76

Nov 2025

All-time low

3

Jan 2023

Average rank

38

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
32
3
67
91
Price/Earnings
19
3
3
41
Price/Book
13
5
43
75
Dividend Yield
71
8
17
27
Value (overall)
27
5
14
39

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sigma Healthcare with its peers
Ebos
NZC:EBO
40
CountryAustralia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Chong Kun Dang
KSC:185750
55
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Green Cross
KSC:005250
28
CountrySouth Korea
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Handok
KSC:002390
15
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
GC Biopharma
KSC:006280
52
CountrySouth Korea
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Hisamitsu Pharmaceutical
TYO:4530
61
CountryJapan
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →